HighTower Advisors, LLC - TETRALOGIC PHARMACEUTICALS C ownership

TETRALOGIC PHARMACEUTICALS C's ticker is TLOG and the CUSIP is 88165U109. A total of 1 filers reported holding TETRALOGIC PHARMACEUTICALS C in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of TETRALOGIC PHARMACEUTICALS C
ValueSharesWeighting
Q3 2016$5,000
-37.5%
27,8700.0%0.00%
Q2 2016$8,000
+60.0%
27,8700.0%0.00%
Q1 2016$5,000
-91.2%
27,870
-15.2%
0.00%
-100.0%
Q4 2015$57,000
-50.0%
32,870
-46.6%
0.00%
-50.0%
Q3 2015$114,000
-20.8%
61,5140.0%0.00%0.0%
Q2 2015$144,000
-46.5%
61,5140.0%0.00%
-50.0%
Q1 2015$269,000
-9.1%
61,5140.0%0.00%
-20.0%
Q4 2014$296,000
+6.9%
61,514
-7.5%
0.01%0.0%
Q3 2014$277,000
-29.3%
66,5140.0%0.01%
-28.6%
Q2 2014$392,000
-7.5%
66,5140.0%0.01%
-12.5%
Q1 2014$424,00066,5140.01%
Other shareholders
TETRALOGIC PHARMACEUTICALS C shareholders Q3 2023
NameSharesValueWeighting ↓
Clarus Ventures, LLC 4,644,705$19,322,0007.71%
First Washington CORP 185,250$771,0000.44%
SPHERA FUNDS MANAGEMENT LTD. 194,200$808,0000.10%
KINGDON CAPITAL MANAGEMENT, L.L.C. 286,801$1,173,0000.05%
EMERALD ADVISERS, LLC 175,000$728,0000.04%
Pine River Capital Management L.P. 209,900$873,0000.01%
Alyeska Investment Group, L.P. 79,196$329,0000.01%
HighTower Advisors, LLC 66,514$277,0000.01%
Tower Research Capital LLC (TRC) 1,441$6,0000.00%
First Eagle Investment Management, LLC 114,456$476,0000.00%
View complete list of TETRALOGIC PHARMACEUTICALS C shareholders